Home > Quotes > BCR

C.R. Bard, Inc. Stock Quote & Summary Data

BCR 
$107.41
*  
0.76
  negative  
0.71%
Get BCR Alerts
*Delayed - data as of May 17, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

1 Year Target: 109.25
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 646,565
Previous Close: $ 106.65
52 Week High /Low: $ 108.31 / $ 93.69
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. 8,644,556,368
P/E Ratio: 19.04
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 17.06
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 5.64
Annualized dividend $ 0.80
Ex Dividend Date Apr. 25, 2013
Dividend Payment Date May 10, 2013
Current Yield 0.75 %
Beta 0.6

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

ETFs with BCR as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.46% SPDR S&P Health Care Equipment (XHE) +1.01  (1.70%)

We make it easy to follow the leaders. PowerShares QQQ. 100 companies at the top of innovation in one fund.


*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

**Green highlights the top performing ETF by % change in the past 100 days.

 Company Description (as filed with the SEC)

C. R. Bard, Inc. and its subsidiaries (the “company” or “Bard”) are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Charles Russell Bard founded the company in 1907. In 1923, the company was incorporated as C. R. Bard, Inc. and distributed an assortment of urological and surgical products. Bard became a publicly traded company in 1963 and began trading on the New York Stock Exchange five years later. Currently, the company sells a broad range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. In general, Bard’s products are intended to be used once and then discarded or implanted either temporarily or permanently. The company participates in the markets for vascular, urology, oncology and surgical specialty products.  ... More ...  



News Headlines for BCR

Dividend Champions: 4 Increases Expected By July 31
5/16/2013 3:15:00 AM - Seeking Alpha
2ND UPDATE: C.R. Bard to Pay $48.3 Million to Settle Kickback Case -DOJ
5/13/2013 7:22:00 PM - Dow Jones Business News
Medical Device Company C.R. Bard Pays $48.2 Million to Settle Whistleblower Lawsuit in Georgia
5/13/2013 5:31:00 PM - PR Newswire
Coppersmith Capital Announces Nomination of Three Highly-Qualified, Independent Candidates for the Alere Board of Directors
5/8/2013 4:56:00 PM - Business Wire
Bard to Host Investor Conference
5/3/2013 11:00:00 AM - Business Wire
 

Consensus Recommendation